Replies to post #329293 on Innovation Pharmaceuticals Inc (IPIX)

[Rdunn88]

GMU indicated testing would be completed by end of August... To still be testing past the original time-frame is interesting? Did Leo send them another 35K? Or, is testing once per/week and have fallen behind? This entire PR chain from IPIX does not compute as to why testing continues with no peer review as of October 22nd...


https://www.news-medical.net/news/20200605/George-Mason-researcher-examining-the-use-of-Brilacidin-for-treatment-of-coronavirus-infections.aspx

As part of this project, Narayanan will first determine the EC50 values, or the concentration of the drug that gives a half-maximal response.

From there, Naryanan and her collaborators will evaluate if Brilacidin has direct virus-killing activity.

They will also assess whether Brilacidin can be provided as a second dose to infected cells without inducing toxicity.

As they work, the researchers will time their experiments to determine the appropriate timing of treatment.

Funding for this research began in May 2020 and will conclude in late August 2020.

[loanranger]

"I get the feeling RBL is going to perform in vivo testing now and will be releasing the peer review doc next September"

Do you think the Company "misspoke" here?
"The lead researchers at both the RBL and at the PHRI have informed the Company they plan to submit their findings, separately, upon completion of in vitro testing, for peer-review publication."
Or do you think the RBL and PHRI have changed their plan?

Note that the bold, italic typeface is in the Company's version. I didn't add it.

http://www.ipharminc.com/press-release/2020/6/11/innovation-pharmaceuticals-collaborating-with-regional-biocontainment-lab-on-grant-application-to-research-brilacidin-as-a-pan-coronavirus-therapeutic



I just reread your statement and it came to me that you were kidding. At least about the "next September" part. The rest, maybe not.